F18.929
Inhalant use, unspecified with intoxication, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant use involves breathing in chemical vapors from household products or industrial substances with the intent of achieving a psychoactive or mind-altering effect. The ICD-10 code F18.929 refers to cases where inhalant use results in intoxication, but specifics about the substance or level of intoxication are not provided. This condition is a concern due to its potential for serious health consequences, including sudden death, brain damage, and other long-term effects. Recognizing the signs and understanding the nature of inhalant intoxication can aid in seeking proper support and intervention.
Causes & Symptoms
Clinical Causes: Peer pressure, especially among adolescents or young adults seeking a quick high. Availability of household products rich in chemicals like solvents, aerosols, or gases. Curiosity about altered mental states without awareness of the risks involved. Mental health issues, such as depression or anxiety, leading individuals to seek relief or escape. Lack of awareness regarding the dangers of inhaling chemical vapors.
Key Symptoms: Dizziness or lightheadedness Euphoria or a feeling of being intoxicated Slurred speech Lack of coordination or clumsiness Nausea or vomiting Headaches Altered mental state, including confusion or hallucinations Rapid heartbeat or irregular pulse Respiratory difficulties Unconsciousness in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive medical history review, including recent inhalant use, and physical examination. Healthcare providers may perform laboratory tests, such as blood or urine analysis, to detect chemicals or metabolites associated with inhalants. In cases of suspected inhalant intoxication, especially if the person is unconscious or unable to communicate, emergency assessment and stabilization are priorities. The absence of specific information about the inhalant makes diagnosis reliant on clinical presentation and history.
Treatment Protocols: Treatment focuses on managing the symptoms of intoxication and preventing further inhalant use. Immediate interventions may include ensuring airway management, providing oxygen, and monitoring vital signs. Psychological support and counseling are crucial for addressing underlying causes, such as behavioral or mental health issues. Long-term recovery may involve behavioral therapy, support groups, and education about the risks of inhalant use. In severe cases, hospitalization and specialized medical interventions might be necessary to manage complications like organ damage or neurological impairments.
Clinical Advice & FAQs
Billing Guidance
Is F18.929 a billable ICD-10 code?
Yes, F18.929 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.929?
Clinical documentation must specify the nature of Inhalant use, unspecified with intoxication, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
